Skip to main content
Heath Skinner, MD, Radiation Oncology, Pittsburgh, PA

Heath Devin Skinner MD PhD

Gastrointestinal Cancer, Head & Neck, Thoracic Cancer


Associate Professor

Join to View Full Profile
  • 5230 Centre AvePittsburgh, PA 15232

  • Phone+1 412-623-3275

Dr. Skinner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2008 - 2012
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 2007

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2018 - 2026
  • TX State Medical License
    TX State Medical License 2011 - 2022
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Personalized Radiation Boosts Cancer Treatment: Medicine’s Next Big Thing?
    Personalized Radiation Boosts Cancer Treatment: Medicine’s Next Big Thing?April 12th, 2022
  • Study Identifies Cancer Features That Could Guide Personalised Radiotherapy
    Study Identifies Cancer Features That Could Guide Personalised RadiotherapyNovember 4th, 2021
  • Study Identifies Cancer Features That Could Guide Personalized Radiotherapy
    Study Identifies Cancer Features That Could Guide Personalized RadiotherapyNovember 3rd, 2021
  • Join now to see all

Grant Support

  • Targeting non-canonical p16 signaling to improve radiation response and outcome in head and neck cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
  • Head and Neck Cancer SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2004–2027
  • Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell CarcinomaYALE UNIVERSITY2023–2025
  • Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticlesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: